Skip to content

Clinical trials

Hypertension, Portal trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Portal Phase: Not applicable Clear all

120 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20052
20074
20083
20104
20111
20125
20133
20145
20154
20166
201710
20183
20194
20204
20219
20224
202315
20247
202511
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Unknown status36
Recruiting18
Not yet recruiting14
Terminated4
Withdrawn3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
West China Hospital10
Nanfang Hospital, Southern Medical University6
Northern Jiangsu People's Hospital5
Shanghai Zhongshan Hospital5
Sun Yat-sen University4
Assistance Publique - Hôpitaux de Paris3
Air Force Military Medical University, China2
Beijing Friendship Hospital2
Centre Hospitalier Universitaire de Besancon2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Portal120
Fibrosis38
Liver Cirrhosis33
Esophageal and Gastric Varices14
Ascites8
Hepatic Encephalopathy8
Hypersplenism5
Liver Diseases5
Gastrointestinal Hemorrhage3
Sarcopenia3

Trials

Showing 26 to 50 of 120. Each trial links to its page on Pharma Observatory.

20 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.